MUMBAI, India, March 15 -- Intellectual Property India has published a patent application (202517015876 A) filed by Myokardia, Inc., Brisbane, U.S.A., on Feb. 24, for 'crystalline forms of (6s,7s)-6-fluoro-7-(2-fluoro-5-methylphenyl)- 3-(tetrahydro-2h-pyran-4-yl)- 5,6,7,8-tetrahydropyrido[2,3- d]pyrimidine-2,4(1h,3h)-dione.'

Inventor(s) include Yu, Ying; Zhang, David John; Wang, Juan; Huang, Neal; Loughrey, Jonathan; Sharp, Lorraine; Dalens, Catherine; Taillez, Franck; Menegotto, Jerome; Tumma, Harikirshna; Wan, Lin; Wang, Wei; Yang, Rongfei; Li, Zheng Jane; Wang, Ruiping; and Lu, Yue.

The application for the patent was published on March 14, under issue no. 11/2025.

According to the abstract released by the Intellectual Property India: ...